Sr. No. | Indicator | RHCse(n = 16) | BHUsf(n = 16) | All PHCCsg(n = 32) | p-value |
---|---|---|---|---|---|
1 | Prescriptions with one or more AMsb, % (range) | 79.3 (68.9–86.2) | 83.8 (71.4–89.1) | 81.5 (68.9–89.1) | < 0.001 |
2 | AMs prescribed per prescription, mean (range) | 1.3 (1.1–1.5) | 1.5 (1.2–1.7) | 1.4 (1.1–1.7) | < 0.001 |
3 | AMs prescribed from FL/EMLh, % | 100 | 100 | 100 | -------a |
4 | Cost (USDc) of AMs prescribed per prescription, mean (range) | 1.5 (0.6–4.3) | 0.9 (0.6–3.7) | 1.3 (0.6–4.3) | < 0.001 |
5 | Duration of prescribed AMs (days), mean (range) | 5.2 (3.3–6.4) | 4.9 (3.7–5.8) | 5.1 (3.3–6.4) | < 0.001 |
6 | Pneumonia patients who received AMs, % | 100 | 100 | 100 | -------a |
7 | Patients who received AMs for Pneumonia in accordance with clinical guidelinesi, % | 0.0 | 0.0 | 0.0 | -------a |
8 | AMs prescribed by INNd, % | 100 | 100 | 100 | -------a |